Bioventus (BVS) Acquisitions (2021 - 2022)
Bioventus posted quarterly Acquisitions of $104.6 million for Q4 2022, up 328.46% year-on-year from $24.4 million in Q4 2021, and up 2092300.0% on a QoQ basis from -$5000.0 in Q3 2022.
Bioventus (BVS) has 2 years of Acquisitions data on file, last reported at $104.6 million in Q4 2022.
- For the quarter ending Q4 2022, Acquisitions rose 328.46% year-over-year to $104.6 million; the trailing twelve-month figure through Oct 2022 stood at $367.7 million (changed N/A YoY), and the FY2021 full-year result was $262.9 million, changed N/A from the prior year.
- Acquisitions for Q4 2022 stood at $104.6 million, up from -$5000.0 in the prior quarter.
- Across five years, Acquisitions topped out at $262.9 million in Q4 2021 and bottomed at -$45.8 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -268.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 1, 2022 | 104.61 Mn |
| Jul 2, 2022 | -5,000.00 |
| Apr 2, 2022 | 236,000.00 |
| Dec 31, 2021 | 262.87 Mn |
| Oct 2, 2021 | -45.79 Mn |
| Jul 3, 2021 | -1,000.00 |
| Apr 3, 2021 | 45.79 Mn |